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The University of Tennessee (UT), the Oak Ridge National
Laboratory (ORNL), and the Kentucky Biomedical Research
Infrastructure Network (KBRIN), have collaborated over
the past decade to share research and educational expertise
in bioinformatics. One result of this collaboration is the
joint sponsorship of an annual regional summit to bring
together researchers, educators and students who are inter-
ested in bioinformatics from a variety of research and edu-
cational institutions. This summit provides unique
opportunities for collaboration and forging links between
members of the various institutions. This year, the Ninth
Annual UT-ORNL-KBRIN Bioinformatics Summit was
held at Lake Barkley State Park in western Kentucky, from
March 19 to 21, 2010. A total of 269 participants pre-regis-
tered for the summit, with 150 from various Tennessee
institutions and 93 from various Kentucky institutions.
A number of additional participants came from universities
and research institutions from other states and countries, e.
g. Emory University, University of British Columbia, Uni-
versity of Cincinnati, Iowa State University, etc. Eighty-one
registrants were faculty, with an additional 94 students, 63
staff, and 31 postdoctoral participants.
The conference program consisted of three days of
presentations. The first day included a pre-summit of
talks by researchers from Kentucky institutions, two
workshops on the use of Bioconductor for DNA micro-
array data analysis, and a session on Next Generation
Sequencing. The next two days were dedicated to scien-
tific presentations divided into two primary sessions on
Epigenetics and Medical Informatics.
Pre-Summit Kentucky bioinformatics session
Dr. Nigel Cooper, the project director of KBRIN, started
the pre-summit Kentucky Bioinformatics session with a
summary of Bioinformatics in the state of Kentucky. Dr.
Cooper reviewed the history, development and current
state of bioinformatics programs in Kentucky institu-
tions, as well as plans for the future. The presentation
highlighted the many sources of funding providing sup-
port for the various bioinformatics initiatives, the under-
graduate, graduate, and post-graduate programs
currently underway, as well as physical resources avail-
able to bioinformatics researchers in Kentucky. Dr.
Cooper also emphasized the need to have institutional
support in the grant application process both for conti-
nuing grant support and in applying for larger grants to
allow bioinformatics research to move forward in the
future.
The remaining talks of the pre-summit session high-
lighted current bioinformatics research from faculty at
various Kentucky institutions. The subjects covered
included sequence analysis, next generation sequencing,
transcriptomics, proteomics and metabolomics.
In the first research talk, Dr. Eric Rouchka of the Uni-
versity of Louisville, used sequence analysis of the 5’
untranslated region (UTR) of 18000 mouse transcripts
to determine those that may be translationally regulated
by CPEB1 [1]. Regulation of gene expression at the
translational level is important because it allows the cell
to create a pool of mRNA transcript that can be quickly
translated to protein without the need to start transcrip-
tion. This work required a model of the CPEB1 binding
site, and a scoring method that considered how many
binding sites the 5’ UTR contained in addition to how
well the sites matched the consensus sequence. Of the
18000 transcripts examined, 1200 were found with a
high score and three binding sites. Ontological analysis
of those genes determined a subset that appears to be
functionally related.
The next talk, by Dr. Arnold Stromberg from Ken-
tucky University, highlighted a rather unusual situation
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in DNA microarray analysis, having only one sample
available for each treatment under investigation. In
DNA microarray studies, with few exceptions, current
practice is to have multiple samples for each treatment
under investigation. However, in this study multiple
samples were not possible. To answer the biological
questions being considered, namely which samples were
most similar and which genes show differential expres-
sion between two of the samples, Dr. Stromberg exam-
ined the various comparisons between pairs of samples,
as well as the expression patterns across all four sam-
ples. Two important considerations emerged in this ana-
lysis, that of false positives, and the determination of
genes that are truly “unexpressed”.
Dr. Ted Kalbfleisch from the University of Louisville
presented his work on assessing the prevalence of the
LINE-1 retrotransposon using Next Generation
Sequence (NGS) data. The long interspersed nuclear ele-
ment 1 (LINE-1) is a repeat sequence that has been
found pervasively throughout the genome. The LINE-1
element is important because it has the ability to re-
insert copies of itself into the genome, thereby causing
changes in gene regulation, overall expression, or gener-
ating splice isoforms of a gene. This action has been
previously documented as the causative agent in some
diseases. However, the true prevalence of LINE-1 in the
human genome is unknown, and until the advent of
NGS was very difficult to assess. However, even with
the availability of NGS data, determining the frequency
of this element in the genome is difficult due to its
repeatability, the very thing that is normally removed
from consideration during sequence assembly. Using
short portions of the known LINE-1 sequence, Dr. Kalb-
fleisch discovered at least 22 insertions that are cur-
rently being verified in the lab. Future work includes
developing an assay to determine a comprehensive
LINE-1 insertion profile, as well as the screening of
large populations to fully characterize the variation pre-
sent in the human population.
Dr. Susmita Datta presented her work regarding an
improved automated method for detecting monoisotopic
peaks in MS data. Automated peak detection in MS
data analysis is important because of the continued use
of various MS methods in both metabolomics and pro-
teomics, however the amount of data generated in any
given MS run is overwhelming to be able to analyze by
hand, and current peak detection methods mistakenly
identify peaks due to many different factors, including
the presence of molecules with overlapping mass pro-
files. To allow detection of the peaks, Dr. Datta mod-
elled the isotopic distribution of the peptides using a
mixture of location shifted Poisson distributions, and an
EM algorithm to determine the weighting parameter of
the distributions. Statistical analysis and comparison
with the LIMPIC method showed improvement in the
number of detected peaks and their identification.
Dr. Ryan Gill from the University of Louisville pre-
sented his work on the determination of differences in
gene networks between two biological samples. Tradi-
tional DNA microarray analysis focuses on generating
lists of differentially expressed genes; however there may
be greater significance in identifying how gene associa-
tion networks change between conditions. To determine
if networks have changed between conditions, however;
one must be able to statistically differentiate between
two networks. Dr. Gill focused on the methods used to
determine differential connectivity of a single gene or
class of genes, and differences in modular structure [2].
Particularly important in this work was the determina-
tion of the sensitivity of the differential score to the net-
work construction parameters, as these will influence
the final networks obtained from the underlying data.
Using data from an experiment designed to determine
the underlying genetic changes between fat and lean
mice, Dr. Gill demonstrated the results and effectiveness
of the differential measure developed.
Dr. Xiang Zhang of the University of Louisville pre-
sented work on developing a metabolic pipeline geared
towards solving three challenges in metabolomics bioin-
formatics: metabolite identification, metabolite quantifi-
cation, and the visualization of metabolite networks. In
contrast to many other methods, Dr. Zhang’s pipeline
uses an in-silico method to predict the gas chromato-
graphic retention times of the possible metabolites. This
is followed by a peak alignment method that considers
both dimensions of separation and the spectra of the
molecules to allow peak alignment over different tem-
perature ranges in the GC column. Using a combination
of significance scores from different statistical tests,
those molecules that are regulated by the process under
investigation are then determined. The inter-molecular
correlations can then be visualized using the SysNet [3]
software. This workflow has provided Dr. Zhang and
colleagues with many interesting insights into various
biological problems.
The final talk of the pre-summit session was presented
by Dr. Guy Brock on the biological impact of missing
value imputation on the downstream analysis of DNA
microarray data [4]. DNA microarrays frequently have
missing expression values, and a common solution to
this problem is to impute values using different meth-
ods. Although many different studies have examined the
problem of missing value imputation, this study was
unique in that it examined the ability of the imputation
methods to recreate the original data, performance mea-
sures used to determine which method should be used,
impact of the methods on the down-stream analysis
using three different biological impact measures.
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Bioconductor workshops
Dr. Guy Brock began the official summit program with
two workshops on the use of R and Bioconductor [5] for
bioinformatics data analysis. The first workshop started
by providing a basic introduction to the R environment,
as well as an overview of the philosophy and capabilities
of R and the Bioconductor suite. This was followed by an
introduction to the ExpressionSet data structure and
methods used to interact with the underlying data. Using
the ALL expression data set available in Bioconductor,
attendees were walked through a typical data analysis
workflow to determine which genes are differentially
expressed in a DNA microarray experiment.
The second workshop continued by introducing some
of the tools available to the researcher who has a list of
differentially expressed genes and is searching for biolo-
gical commonalities among them. These include exam-
ining gene annotations such as gene names and the
Gene Ontology. Dr. Brock also reviewed the use of clVa-
lid [6], a recently released R package for cluster valida-
tion, which can be used to determine the validity of
gene clustering results based on various measures.
Finally, the use of Gene Set Enrichment Analysis
(GSEA) to determine the presence of over-represented
biological functions or pathways was reviewed.
Next generation sequencing
The Next Generation Sequencing (NGS) session was
kicked off by Dr. Ted Kalbfleisch from the University of
Louisville with a thorough introduction to this rapidly
developing field. Dr. Kalbfleisch reviewed DNA sequen-
cing methods from the early days of Maxam-Gilbert
sequencing through the current slate of Next Genera-
tion sequencers such as the 454 and SoLiD platforms.
He also reviewed the various software tools used to per-
form alignment and raw assembly with commentary on
some of the pros and cons associated with each method,
in addition to the many applications for which NGS is
being used. His presentation ended with a discussion of
a particular examination of genetic variation of the
Line-1 retrotransposon from NGS data that is publicly
available. This project required aligning known Line-1
insertion patterns to whole genome NGS data for identi-
fication of novel insertion sites.
Dr. David Sexton of Vanderbilt University followed up
with an examination of the resources required to man-
age the massive amounts of data produced by NGS
based upon his experience as the Director of the Com-
putational Genomics Core in the Center for Human
Genetics Research [7]. Dr. Sexton continually empha-
sized the need to be able to handle the incredible
volumes of data that these sequencers generate, in terms
of storage, backup, transport, and analysis. For every
consideration, he described the currently implemented
solutions at Vanderbilt, giving attendees a glimpse into
the day-to-day operations of the NGS center.
The last talk of the day was by Dr. Steven Jones from
the University of British Columbia. Dr. Jones focussed
on the use of NGS to characterize individual mutations
in cancer cells, and thereby offer tailored therapies, or
individualized genomics. Using NGS, they were able to
determine which gene pathways were modified in indivi-
dual cancers, and suggest appropriate treatments for the
individual. This stands in marked contrast to the pre-
viously accepted method of isolating one particular
strain of cancer cells and treating it as a representative
for other cancers in the same bodily tissue [8]. One par-
ticularly interesting example involved one individual
cancer where the mutations were characterized over
time in response to treatment, with examination of the
various gene pathways that were disrupted as the cancer
underwent further mutation in response to the
treatments.
Epigenetics
The second day of talks began with the session on Epi-
genetics. Dr. James Cheverud of Washington University
presented his research on epigenetic sources of variation
in mice obesity. This work involved the crossing of very
large (overweight, LG) females with very small (lean,
SM) males, and correlating the resultant phenotypes
with various loci, and determining how the interactions
between loci lead to a particular phenotype [9-11]. Parti-
cular emphasis was placed on examining combinations
of gene-effects to provide more explanatory power than
examining single gene effects in isolation.
Dr. Rosanna Weksberg from the Hospital for Sick
Children at the University of Toronto presented
research on the genetic imprinting effect in Beckwith-
Wiedemann syndrome (BWS) [12,13] which has both
genetic causes and epigenetic phenotypes. Two groups
of genes have been shown to have changed methylation
patterns in connection with BWS, leading to changes in
their expression. Dr. Weksberg also discussed Prader
Willi Syndrome, and Russell-Silver Syndrome, which are
additional human imprinting disorders associated with
growth.
Rounding out the epigenetics session was Dr. Robert
Lane from the University of Utah Department of Pedia-
trics and his examination of genetic imprinting via his-
tone methylation as a mechanism of adaptation. It has
been known for some time that the methylation state of
genes affects their expression, however there are still
many questions regarding the causes and effects of parti-
cular histone methylation patterns. The primary system
examined by Dr. Lane was intrauterine growth restriction
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(IUGR), a condition of restricted growth in the embryo
that leads to altered expression of insulin-like growth fac-
tor 1 (IGF-1) in the adult, with subsequent effects on
growth and development [14,15]. A rat model of IUGR
combined with examination of the methylation patterns
of the histones found reproducible changes to the methy-
lation of particular histone residues that were also gene
position dependent. This resulted in a change of the ratio
of particular IGF-1 transcripts, thereby resulting in
altered phenotypes. Similar examination of pups of
hyperglycemic rats (simulating diabetic pregnancies)
revealed analogous changes in methylation of the his-
tones. Incredibly, they were able to prevent the phenoty-
pic changes and reprogram the methylation via
supplementation with essential nutrients, thereby re-
establishing IGF-1 expression to control levels.
Following the poster session and evening buffet, there
was an overview of Computable Genomix’s Gene
Indexer program. Gene Indexer is an automated latent
semantic indexing engine that extracts both explicit and
implicit relationships from the literature. It is efficient
and uses an investigator’s questions, not predetermined
pathways or ontologies, to interrogate the scientific lit-
erature and determines the functional cohesiveness of
any groups of genes.
Dr. Robert Hettich of the Oak Ridge National Labora-
tory presented work on the use of -omics to examine
human gut microbial communities and their involve-
ment in Crohn’s disease [16,17]. This work required
examining the metaproteomes and metagenomes, or set
of all proteins and genes from a heterogeneous popula-
tion of bacteria in twins where one, both or neither suf-
fered from Crohn’s disease (CD) or Ulcerative Colitis
(UC). Dr. Hettich’s group specifically performed the pro-
teomics work to identify as many expressed proteins as
possible in the stool samples based on the gene
sequences that had been previously determined. They
were able to identify changes in the composition of the
microbiome and the metaproteome that correlated with
the presence or absence of disease, providing rich data
sets that will require extensive follow-up.
Day two’s keynote address was given by Dr. Mike
Hawrylycz of the Allen Institute for Brain Science on the
informatics of large scale digital aliasing in neuroscience
[18,19]. As an example, Dr. Hawrylycz provided an in-
depth examination of the information required to create
the Developing Mouse Brain Atlas. This resource com-
bines 2 D slices of brain tissue, 3 D models of the brain
changing during development [20], with in-situ hybridi-
zation gene expression levels for ~2000 genes. This pub-
licly available resource allows anyone to examine the
expression levels of these genes over the developmental
stages and determine those genes that have correlated
expression either temporally or spatially. A variety of
analysis tools and metrics are built into the Atlas, provid-
ing a wealth of information regarding gene expression in
the brain to the interested researcher.
Medical informatics
Only one talk was presented in the Medical Informatics
session, by Dr. Myriam Fornage from the University of
Texas at Houston, on the search for genes responsible
for vascular diseases in the brain. Although studies have
shown that by far the greatest indicators for vascular
disease are age, sex, and high blood pressure, it may be
that particular genetic factors predispose individuals to
ischemic injuries in the brain. This has been borne out
by previous studies that indicate many individuals suffer
from pre-clinical lesions, and that true ischemic stroke
tends to be “the tip of the iceberg”, in that it is a clinical
symptom of a long underlying process. Dr. Fornage
reported on a series of genome wide association studies
performed to try and determine genes that may make it
more likely that an individual will suffer from brain vas-
cular disease (BVD). A variety of SNP’s have been iden-
tified and confirmed in follow up studies. Two genes in
particular were found to be associated with a higher risk
of BVD, Ninj2 and Wnk1 [21]. Ninj2 is a cell surface
adhesion molecule that is induced after nerve injury,
and is theorized to affect how the brain tolerates/
recovers from ischemic insults. Wnk1 is a kinase that
has been previously associated with hypertension, and is
theorized to promote injury to the brain. Using a mouse
ischemia model, the expression of both genes was fol-
lowed over time following injury to the brain, and the
expression of both was shown to be concordant with
their known roles. Although GWAS analyses are identi-
fying new genetic variants involved in BVD, the effect of
many of them is small, thereby requiring large sample
sizes to allow their detection. A question that does
result though, is how small an effect is too small to be
clinically relevant and not worthy of further investiga-
tion or drug development? In addition, there is the
potential for more work on examining gene-gene inter-
actions, as it is likely that variants found in conjunction
will have a larger effect.
Posters & short talks
During the two-hour poster session on Saturday after-
noon, fifty-two posters (eighteen more than the previous
year) were presented. The abstracts were divided into
the general groupings of Bioimaging, Bioinformatics of
Health and Disease, Bioinformatics Infrastructure, Com-
parative Genomics, Databases, Functional Genomics,
Gene Regulation, Genome Annotation, Genomics,
Machine Learning/Algorithms, Microarrays, Neu-
roscience, Proteomics, Sequence Analysis, and Structure
and Function Prediction.
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Two sessions (one each on Saturday and Sunday) fea-
tured presentations from the poster abstracts. They
included “Inferring Gene Coexpression Networks for
Low Dose Ionizing Radiation using Graph Theoretical
Algorithms and Systems Genetics” (Gary L. Rogers),
“Integrating metagenomics with metaproteomics for
characterization of the molecular activities of the human
distal gut microbiome in healthy and Crohn’s Disease”
(Alison Erickson), “Discovering Disease-specific Biomar-
ker Genes for Cancer Diagnosis and Prognosis”
(Zhongming Zhao), “Analysis of equine protein-coding
gene structure and expression by RNA-sequencing” (Ste-
ven Coleman), “A systematic pathway-based analysis of
GWAS data revealed susceptibility pathways to schizo-
phrenia” (Peilin Jia), “Association of Genomewide New-
born DNA Methylation Patterns with Maternal Diet,
Birth Weight and SNP Variation” (Ronald Adkins),
“High-throughput sequencing of the DBA/2J mouse
genome” (Rob Williams), and “Subsystems-based servers
for rapid annotation of genomes and metagenomes”
(Rami Aziz).
Future plans
The 2011 Bioinformatics summit will return to the state
of Tennessee in the spring of 2011. Potential focus areas
include current technological trends in molecular biol-
ogy, applications of next-generation sequencing, and sys-
tems biology. The format will likely be expanded to
include more local talks and hands-on workshops at
introductory and advanced levels.
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